Clinical Trial

Myocardial Telomere Recapping Study for Dilated Cardiomyopathy

Study acronym: MERCURY-DCM
Unknown Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2024 (before its estimated July 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to determine the safety and feasibility of giving an adeno-associated viral vector expressing a modified telomerase protein (TERT), driven by cardiac troponin T promoter (AAV9-cTnT-modTERT), to 12 dilated cardiomyopathic patients.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05837143
Lead Sponsor Shanghai East Hospital
Collaborators: Shanghai Juvensis Therapeutics Biotechnology Company Limited
Conditions Heart Failure, Dilated Cardiomyopathy
Enrollment 12 participants
Start Date 2023-03-30
Primary Completion 2025-07-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-16